Pages that link to "Q39683930"

The following pages link to Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib (Q39683930):

Displaying 22 items.

• Can active components of licorice, glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis? (Q26779680) (← links)
• Nonsteroidal Anti-inflammatory Drugs and Risk of Incident Heart Failure: A Systematic Review and Meta-analysis of Observational Studies (Q28079436) (← links)
• Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. (Q30540016) (← links)
• Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity (Q33959603) (← links)
• Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis. (Q36233306) (← links)
• The leukotriene receptor antagonist montelukast and aortic stenosis (Q36562551) (← links)
• Molecular interaction study of N1-p-fluorobenzyl-cymserine with TNF-α , p38 kinase and JNK kinase. (Q36727886) (← links)
• The Effect of Gabapentin Plus Celecoxib on Pain and Associated Complications After Laminectomy (Q36831286) (← links)
• Inflammatory mediators in saliva associated with arterial stiffness and subclinical atherosclerosis. (Q37284714) (← links)
• Non-steroidal anti-inflammatory drugs and the risk of atrial fibrillation: a population-based follow-up study (Q37704435) (← links)
• Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer (Q38027501) (← links)
• Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review (Q38068081) (← links)
• Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes (Q38249105) (← links)
• Anti-inflammatory therapies for atherosclerosis (Q38349757) (← links)
• Celecoxib for the treatment of atherosclerosis. (Q38759585) (← links)
• Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology (Q38777815) (← links)
• The effect of some 4,2 and 5,2 bisthiazole derivatives on nitro-oxidative stress and phagocytosis in acute experimental inflammation. (Q46870956) (← links)
• COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles (Q48004224) (← links)
• Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology. (Q52853892) (← links)
• Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis (Q91253135) (← links)
• Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer (Q92775956) (← links)
• Cardiovascular effects and safety of (non-aspirin) NSAIDs (Q93164270) (← links)